References
- Kitahara CM, Sosa JA. The changing incidence of thyroid cancer. Nat Rev Endocrinol. 2016;12(11):646–53.
- Eszlinger M, Ullmann M, Ruschenburg I, et al. Low malignancy rates in fine-needle aspiration cytologies in a primary care setting in Germany. Thyroid. 2017;27(11):1385–92.
- Gao L, Ma B, Zhou L, et al. The impact of presence of Hashimoto’s thyroiditis on diagnostic accuracy of ultrasound-guided fine-needle aspiration biopsy in subcentimeter thyroid nodules: a retrospective study from FUSCC. Cancer Med. 2017;6(5):1014–22.
- Caleo A, Landolfi L, Vitale M, et al. The diagnostic accuracy of fine-needle cytology of hurthle cell lesions; A comprehensive cytological, clinical and ultrasonographic experience. Int J Surg. 2016;28(Suppl 1):S65–9.
- Damiani D, Suciu V, Vielh P. Cytopathology of follicular cell nodules. Endocr Pathol. 2015;26(4):286–90.
- Erdogan M, Erdem N, Cetinkalp S, et al. Demographic, clinical, laboratory, ultrasonographic, and cytological features of patients with Hashimoto’s thyroiditis: results of a university hospital of 769 patients in Turkey. Endocrine. 2009;36(3):486–90.
- Zosin I, Balaş M. Clinical, ultrasonographical and histopathological aspects in Hashimoto’s thyroiditis associated with malignant and benign thyroid nodules. Endokrynol Pol. 2013;64(4):255–62.
- Boi F, Lai ML, Marziani B, et al. High prevalence of suspicious cytology in thyroid nodules associated with positive thyroid autoantibodies. Eur J Endocrinol. 2005;153(5)::637–42.
- Haugen BR, Alexander EK, Bible KC, et al. 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26(1):1–133.
- Shrestha M, Crothers BA, Burch HB. The impact of thyroid nodule size on the risk of malignancy and accuracy of fine-needle aspiration: a 10-year study from a single institution. Thyroid. 2012;22(12):1251–1256.
- Mahajan A, Lin X, Nayar R. Thyroid Bethesda reporting category, ‘suspicious for papillary thyroid carcinoma’, pitfalls and clues to optimize the use of this category. Cytopathology. 2013;24(2)::85–91.
- Bongiovanni M, Papadakis GE, Rouiller N, et al. The Bethesda system for reporting thyroid cytopathology explained for practitioners: frequently asked questions. Thyroid. 2018;28(5):556–65.
- Harvey AM, Truong LD, Mody DR. Diagnostic pitfalls of Hashimoto’s/lymphocytic thyroiditis on fine-needle aspirations and strategies to avoid overdiagnosis. Acta Cytol. 2012;56(4):352–60.
- Baser H, Ozdemir D, Cuhaci N, et al. Hashimoto’s thyroiditis does not affect ultrasonographical, cytological, and histopathological features in patients with papillary thyroid carcinoma. Endocr Pathol. 2015;26(4):356–64.
- Anderson L, Middleton WD, Teefey SA, et al. Hashimoto thyroiditis: part 2, sonographic analysis of benign and malignant nodules in patients with diffuse Hashimoto thyroiditis. Am J Roentgenol. 2010;195(1):216–22.
- Anil C, Goksel S, Gursoy A. Hashimoto’s thyroiditis is not associated with increased risk of thyroid cancer in patients with thyroid nodules: a single-center prospective study. Thyroid. 2010;20(6):601–6.
- Gul K, Dirikoc A, Kiyak G, et al. The association between thyroid carcinoma and Hashimoto’s thyroiditis: the ultrasonographic and histopathologic characteristics of malignant nodules. Thyroid. 2010;20(8):873–8.
- Grani G, Calvanese A, Carbotta G, et al. Thyroid autoimmunity and risk of malignancy in thyroid nodules submitted to fine-needle aspiration cytology. Head Neck. 2015;37(2):260–4.
- Gabalec F, Srbova L, Nova M, et al. Impact of Hashimoto’s thyroiditis, TSH levels, and anti-thyroid antibody positivity on differentiated thyroid carcinoma incidence. Endokrynol Pol. 2016;67(1):48–53.
- Boi F, Pani F, Calo PG, et al. High prevalence of papillary thyroid carcinoma in nodular Hashimoto’s thyroiditis at the first diagnosis and during the follow-up. J Endocrinol Invest. 2018;41(4):395–402.
- Pandit AA, Vijay Warde M, Menon PS. Correlation of number of intrathyroid lymphocytes with antimicrosomal antibody titer in Hashimoto’s thyroiditis. Diagn Cytopathol. 2003;28(2):63–5.
- Rho MH, Kim DW, Hong HP, et al. Diagnostic value of antithyroid peroxidase antibody for incidental autoimmune thyroiditis based on histopathologic results. Endocrine. 2012;42(3):647–52.
- Cibas ES, Baloch ZW, Fellegara G, et al. A prospective assessment defining the limitations of thyroid nodule pathologic evaluation. Ann Intern Med. 2013;159(5):325.
- Olson MT, Boonyaarunnate T, Aragon Han P, et al. A tertiary center’s experience with second review of 3885 thyroid cytopathology specimens. J Clin Endocrinol Metab. 2013;98(4):1450–7.
- Karatzas T, Vasileiadis I, Zapanti E, et al. Thyroglobulin antibodies as a potential predictive marker of papillary thyroid carcinoma in patients with indeterminate cytology. Am J Surg. 2016;212(5):946–52.
- Patel KN, Angell TE, Babiarz J, et al. Performance of a genomic sequencing classifier for the preoperative diagnosis of cytologically indeterminate thyroid nodules. JAMA Surg. 2018;153(9):817–24.